KDM1A microenvironment, its oncogenic potential, and therapeutic significance
Cited 0 times inCited 0 times in
- KDM1A microenvironment, its oncogenic potential, and therapeutic significance
- Ismail, Tayaba; Lee, Hyun-Kyung; Kim, Chowon; Kwon, Taejoon; Park, Tae Joo; Lee, Hyun-Shik
- Histone demethylation; Carcinogenesis; Acute myeloid leukemia; KDM1A; TLL
- Issue Date
- BIOMED CENTRAL LTD
- EPIGENETICS & CHROMATIN, v.11, no., pp.33 -
- The lysine-specific histone demethylase 1A (KDM1A) was the first demethylase to challenge the concept of the irreversible nature of methylation marks. KDM1A, containing a flavin adenine dinucleotide (FAD)-dependent amine oxidase domain, demethylates histone 3 lysine 4 and histone 3 lysine 9 (H3K4me1/2 and H3K9me1/2). It has emerged as an epigenetic developmental regulator and was shown to be involved in carcinogenesis. The functional diversity of KDM1A originates from its complex structure and interactions with transcription factors, promoters, enhancers, oncoproteins, and tumor-associated genes (tumor suppressors and activators). In this review, we discuss the microenvironment of KDM1A in cancer progression that enables this protein to activate or repress target gene expression, thus making it an important epigenetic modifier that regulates the growth and differentiation potential of cells. A detailed analysis of the mechanisms underlying the interactions between KDM1A and the associated complexes will help to improve our understanding of epigenetic regulation, which may enable the discovery of more effective anticancer drugs.
- ; Go to Link
Appears in Collections:
- SLS_Journal Papers
- Files in This Item:
can give you direct access to the published full text of this article. (UNISTARs only)
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.